NYU Langone Hematology Oncology Associates-Mineola — Mineola, New York

NYU Langone Hematology Oncology Associates-Mineola is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

NYU Langone Hematology Oncology Associates-Mineola has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Cancer, Non Small Cell Lung Cancer, Solid Tumors, Adult.

Sponsors: Bristol-Myers Squibb, Tango Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mineola

Browse all research sites in New York · View every site in Mineola

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Hematology Oncology Associates-Mineola?

NYU Langone Hematology Oncology Associates-Mineola has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Hematology Oncology Associates-Mineola conducted?

NYU Langone Hematology Oncology Associates-Mineola has 2 clinical trials on record, with 2 currently active. Their work covers Cancer, Non Small Cell Lung Cancer, Solid Tumors, Adult.

Is NYU Langone Hematology Oncology Associates-Mineola accredited by Crixeo Clinical Trials?

NYU Langone Hematology Oncology Associates-Mineola has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Hematology Oncology Associates-Mineola?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.